Aetna modified CPB 0473 for travel vaccines, effective March 3, 2026. Here's what billing teams need to know.
Aetna, a CVS Health company, updated its travel vaccine coverage policy under CPB 0473 in the Aetna system on March 3, 2026. This modification touches 24 CPT codes and five HCPCS codes — including CPT 90589 and 90593 for chikungunya vaccines, CPT 90717 for yellow fever, CPT 90675 and 90676 for rabies, and several immunization administration codes (90460–90484). If your practice bills travel vaccines for Aetna members, you need to verify your charge capture reflects the current selection criteria before submitting claims.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Vaccines for Travel — CPB 0473 |
| Policy Code | CPB 0473 |
| Change Type | Modified |
| Effective Date | March 3, 2026 |
| Impact Level | Medium |
| Specialties Affected | Travel medicine, infectious disease, primary care, pediatrics, occupational health |
| Key Action | Audit your travel vaccine charge capture against CPB 0473's current selection criteria and update documentation templates before billing any covered CPT codes post-March 3, 2026 |
Aetna Travel Vaccine Coverage Criteria and Medical Necessity Requirements 2026
The Aetna travel vaccine coverage policy under CPB 0473 covers specific vaccines when they meet medical necessity criteria tied to destination, age, and clinical indication. Coverage is not automatic. Each vaccine has its own indications, standard administration schedule, and contraindications defined in the policy.
The central medical necessity standard is destination-appropriate clinical indication. For example, CPT 90717 (yellow fever vaccine) applies when travel to endemic regions creates documented exposure risk. CPT 90738 (Japanese encephalitis) follows a similar logic — coverage requires documented travel to an area where the virus circulates. These are not open-ended reimbursement opportunities. Aetna expects specific, documented indications.
CPT 90625 for oral cholera vaccine has an explicit age restriction in the policy: covered for ages 2–64 only. Bill this code outside that range and you are looking at a claim denial. Make sure your charge capture systems enforce that age boundary.
Rabies pre-exposure prophylaxis gets two separate codes: CPT 90675 for intramuscular use and CPT 90676 for intradermal use. Both are covered when selection criteria are met, but route of administration matters for code selection. Billing 90675 when the intradermal route was used is a coding error — it creates audit exposure.
The chikungunya vaccine codes (CPT 90589 for live attenuated and 90593 for recombinant) are newer additions to this code set. Coverage criteria apply to both, and formulation matters. Document which formulation was administered, because these are not interchangeable codes.
This policy does not explicitly call out prior authorization requirements in the summarized criteria, but Aetna plan designs vary. Depending on the specific member's benefit structure, prior authorization may apply — especially for pre-exposure rabies prophylaxis or Ebola vaccine (CPT 90758). Confirm PA requirements through Aetna's provider portal for individual members before administering higher-cost vaccines.
Coverage Indications at a Glance
| Vaccine | CPT Code(s) | Coverage Status | Key Notes |
|---|---|---|---|
| Chikungunya (live attenuated) | 90589 | Covered — selection criteria required | Document travel destination and exposure risk |
| Chikungunya (recombinant) | 90593 | Covered — selection criteria required | Formulation-specific; do not swap with 90589 |
| Cholera (live, oral) | 90625 | Covered — ages 2–64 only | Hard age limit; claim will deny outside range |
| Tick-borne encephalitis (0.25 mL) | 90626 | Covered — selection criteria required | Destination-based indication required |
| Tick-borne encephalitis (0.5 mL) | 90627 | Covered — selection criteria required | Dose-specific code; confirm volume administered |
| Rabies (intramuscular) | 90675 | Covered — selection criteria required | Route-specific; verify IM administration |
| Rabies (intradermal) | 90676 | Covered — selection criteria required | Route-specific; verify ID administration |
| Typhoid (live, oral) | 90690 | Covered — selection criteria required | Document indication and travel destination |
| Typhoid (ViCPs, intramuscular) | 90691 | Covered — selection criteria required | Separate code from oral formulation |
| MMR | 90707 | Covered — selection criteria required | Standard travel vaccination indication |
| MMRV | 90710 | Covered — selection criteria required | Age-appropriate indications apply |
| Yellow fever | 90717 | Covered — selection criteria required | Endemic destination documentation required |
| Japanese encephalitis (inactivated) | 90738 | Covered — selection criteria required | Travel to endemic region required |
| Zaire ebolavirus (live) | 90758 | Covered — selection criteria required | High-cost vaccine — verify PA before administering |
| Hepatitis B administration | G0010 | Covered — selection criteria required | Administration code; pair with appropriate vaccine |
Aetna Travel Vaccine Billing Guidelines and Action Items 2026
These action items apply to any practice billing Aetna for travel vaccines under CPB 0473 after March 3, 2026.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture against the updated CPB 0473 selection criteria. Pull your last 90 days of travel vaccine claims and confirm every code maps to a documented, covered indication. Focus first on CPT 90625 (cholera) — the age 2–64 restriction is the most common hard denial trigger in this code set. |
| 2 | Separate rabies codes by route of administration. CPT 90675 (intramuscular) and 90676 (intradermal) are distinct codes. Update your charge capture templates to prompt the clinician or nurse to document route at the point of care. Billing guidelines require you to code what was actually administered. |
| 3 | Pair every vaccine code with the correct administration code. For patients 18 and under, use CPT 90460 (with counseling) and 90461 for each additional component. For adults, use 90471 and 90472 for injection routes, or 90473 and 90474 for intranasal or oral routes (relevant for CPT 90625 and 90690). Mismatched vaccine and administration codes are a top reason for travel vaccine billing claim denial. |
| 4 | Bill immunization counseling codes when documentation supports them. If a physician or qualified health care professional provides counseling, CPT 90482 (first vaccine, up to 10 minutes), 90483 (greater than 10 to 20 minutes), and 90484 (greater than 20 minutes) are available under this policy. HCPCS G0310–G0313 are the parallel codes on the HCPCS side. These reimbursement opportunities are consistently underclaimed in travel medicine practices. |
| 5 | Link ICD-10-CM Z23 to every claim. Z23 (encounter for immunization) is the designated diagnosis code under CPB 0473. It should appear on every travel vaccine claim. Missing or incorrect diagnosis coding is a mechanical denial — easy to prevent, surprisingly common. |
| 6 | Verify prior authorization on high-cost vaccines before administering. CPT 90758 (Ebola vaccine) and pre-exposure rabies prophylaxis (90675 and 90676) carry higher cost and clinical complexity. Even if CPB 0473 doesn't mandate PA universally, individual Aetna plan designs may. Confirm PA status through Aetna's provider portal before the appointment. A denied claim for a $500+ vaccine hurts your practice more than the PA phone call. |
| 7 | Update your documentation templates to capture destination and exposure risk. Medical necessity for travel vaccines depends on documented clinical rationale tied to the traveler's destination, itinerary, and exposure risk. A generic "patient is traveling" note will not support a claim. Your note needs to name the destination, the risk, and why the specific vaccine was indicated. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Travel Vaccines Under CPB 0473
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Description |
|---|---|
| 90589 | Chikungunya virus vaccine, live attenuated, for intramuscular use |
| 90593 | Chikungunya virus vaccine, recombinant, for intramuscular use |
| 90625 | Cholera vaccine, live, adult dosage, 1 dose schedule, for oral use — covered ages 2–64 only |
| 90626 | Tick-borne encephalitis virus vaccine, inactivated; 0.25 mL dosage, for intramuscular use |
| 90627 | Tick-borne encephalitis virus vaccine, inactivated; 0.5 mL dosage, for intramuscular use |
| 90675 | Rabies vaccine, for intramuscular use |
| 90676 | Rabies vaccine, for intradermal use |
| 90690 | Typhoid vaccine, live, oral |
| 90691 | Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use |
| 90707 | Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use |
| 90710 | Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use |
| 90717 | Yellow fever vaccine, live, for subcutaneous use |
| 90738 | Japanese encephalitis virus vaccine, inactivated, for intramuscular use |
| 90758 | Zaire ebolavirus vaccine, live, for intramuscular use |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Description |
|---|---|
| G0010 | Administration of hepatitis B vaccine |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| Z23 | Encounter for immunization |
A note on the code set: the policy references CPT 90482, 90483, and 90484 alongside their HCPCS counterparts G0310–G0313 for immunization counseling. These codes cover the same clinical service but apply in different billing contexts. Which set you use depends on payer and place of service. If you bill a mix of Medicare and commercial Aetna, your billing team needs to know which code family applies in each scenario. Talk to your billing consultant if you're unsure how to separate these in a multi-payer environment.
The effective date of March 3, 2026 applies to this modification of CPB 0473. Claims submitted for dates of service on or after that date should reflect the current criteria. Review claims submitted between January 1 and March 3, 2026 to confirm they aligned with the prior version of the policy — if Aetna retroactively reviews, you want your documentation to match whichever version was in effect at the date of service.
Get the Full Picture for CPT 90589
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.